Article Text

Download PDFPDF
Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy
  1. Jay Ramchand,
  2. Agostina M Fava,
  3. Michael Chetrit,
  4. Milind Y Desai
  1. Heart and Vascular Institute, Cleveland Clinic Miller Family Heart and Vascular Institute, Cleveland, Ohio, USA
  1. Correspondence to Dr Milind Y Desai, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA; desaim2{at}ccf.org

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Authors’ reply

We thank Dr Yalta1 and colleagues for the interest in our review article on advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy (HCM).2 The authors highlight the importance of excluding transient LV apical ballooning/ Takotsubo cardiomyopathy (TTC) as a potential mimic of left ventricular apical aneurysm in individuals with hypertrophic cardiomyopathy.

We fully agree that TTC should be distinguished from an apical aneurysm especially considering the presence of an aneurysm may be used as a risk modifier …

View Full Text

Footnotes

  • Twitter @DrJRamchand, @agofava, @DesaiMilindY

  • Contributors All 3 authors participated in the work.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles